Supreme Pharmaceuticals Inc.: Due Diligence Update
April 09 2014 - 4:15PM
Marketwired
Supreme Pharmaceuticals Inc.: Due Diligence Update
CALGARY, ALBERTA--(Marketwired - Apr 9, 2014) - Supreme
Pharmaceuticals Inc. (the "Company")
(TSX-VENTURE:SL)(PINKSHEETS:SPRWF) notes that in respect to its
prior press release on Friday April 4, 2014, the Company will be
utilizing the full 7 business days to complete and conclude the due
diligence period. This means that the Company will report news on
Tuesday, April 15, 2014 with a final decision on the South Okanagan
producing medical marijuana facility.
We apologize for the misperception from the prior press release
that a decision would be made as of April 10, 2014.
The process thus far has been positive and the process is moving
ahead smoothly.
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in policies of the TSX Venture
Exchange) accepts responsibility for the adequacy or accuracy of
this release.
FORWARD-LOOKING INFORMATION
This News Release contains forward-looking statements. The use
of any of the words "anticipate", "continue", "estimate", "expect",
"may", "will", "project", "should", "believe" and similar
expressions are intended to identify forward-looking statements.
Although the Company believes that the expectations and assumptions
on which the forward-looking statements are based are reasonable,
undue reliance should not be placed on the forward-looking
statements because the Company can give no assurance that they will
prove to be correct. Since forward-looking statements address
future events and conditions, by their very nature they involve
inherent risks and uncertainties. These statements speak only as of
the date of this News Release. Actual results could differ
materially from those currently anticipated due to a number of
factors and risks including various risk factors discussed in the
Company's disclosure documents which can be found under the
Company's profile on www.sedar.com. This News Release contains
"forward-looking statements" within the meaning of Section 27A of
the Securities Act of 1933, as amended, and Section 21E the
Securities Exchange Act of 1934, as amended and such
forward-looking statements are made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of
1995.
Supreme Pharmaceuticals Inc.#772 Alastair Ross Technology
Centre3553 - 31st Street NW, Calgary, Alberta, T2L 2K7Phone: (647)
340-6744Email: info@supremepharmaceuticals.comWebsite:
www.supremepharmaceuticals.com